Genus plc’s (GNS) Hold Rating Reaffirmed at Liberum Capital
Genus plc (LON:GNS)‘s stock had its “hold” rating restated by equities research analysts at Liberum Capital in a research note issued to investors on Tuesday, StockTargetPrices.com reports. They currently have a GBX 2,100 ($28.31) target price on the stock. Liberum Capital’s price objective would indicate a potential upside of 3.09% from the company’s previous close.
Other research analysts have also recently issued reports about the company. Peel Hunt reiterated a “buy” rating on shares of Genus plc in a research report on Thursday, June 1st. Numis Securities Ltd reiterated a “hold” rating and set a GBX 1,815 ($24.47) price target on shares of Genus plc in a research report on Thursday, September 7th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of GBX 2,171.67 ($29.28).
Genus plc (GNS) traded up 0.54% during midday trading on Tuesday, reaching GBX 2037.00. 26,851 shares of the company traded hands. The stock’s market capitalization is GBX 1.24 billion. The firm has a 50-day moving average of GBX 1,852.95 and a 200-day moving average of GBX 1,811.22. Genus plc has a 1-year low of GBX 1,652.00 and a 1-year high of GBX 2,113.00.
Genus plc Company Profile
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with MarketBeat.com's FREE daily email newsletter.